Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 96 entries
Sorted by: Best Match Show Resources per page
Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.

Indian journal of nephrology

Torabinejad S, Mardani R, Habibagahi Z, Roozbeh J, Khajedehi P, Pakfetrat M, Banihashemi MA, Banihashemi SJ.
PMID: 22279336
Indian J Nephrol. 2012 Jan;22(1):5-12. doi: 10.4103/0971-4065.91179.

The purpose of this investigation was to assess the correlation of two biomarkers with the occurrence of renal flares in systemic lupus erythematosus (SLE). Urine levels of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor beta (TGF-β) were measured...

Cite
Torabinejad S, Mardani R, Habibagahi Z, et al. Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian J Nephrol. 2012;22(1):5-12doi: 10.4103/0971-4065.91179.
Torabinejad, S., Mardani, R., Habibagahi, Z., Roozbeh, J., Khajedehi, P., Pakfetrat, M., Banihashemi, M. A., & Banihashemi, S. J. (2012). Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian journal of nephrology, 22(1), 5-12. https://doi.org/10.4103/0971-4065.91179
Torabinejad, S, et al. "Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus." Indian journal of nephrology vol. 22,1 (2012): 5-12. doi: https://doi.org/10.4103/0971-4065.91179
Torabinejad S, Mardani R, Habibagahi Z, Roozbeh J, Khajedehi P, Pakfetrat M, Banihashemi MA, Banihashemi SJ. Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian J Nephrol. 2012 Jan;22(1):5-12. doi: 10.4103/0971-4065.91179. PMID: 22279336; PMCID: PMC3263065.
Copy Download .nbib Format: NLM
Prevalence of domestic violence on pregnant women and maternal and neonatal outcomes in Bandar Abbas, Iran.

Electronic physician

Nejatizade AA, Roozbeh N, Yabandeh AP, Dabiri F, Kamjoo A, Shahi A.
PMID: 28979757
Electron Physician. 2017 Aug 01;9(8):5166-5171. doi: 10.19082/5166. eCollection 2017 Aug.

BACKGROUND: Pregnancy by itself, imposes great physical and psychological pressures on a person and consequently, coupled with other stressors such as violence, can have adverse effects on the fetus and mother.OBJECTIVE: To assess the prevalence of domestic violence in...

Cite
Nejatizade AA, Roozbeh N, Yabandeh AP, et al. Prevalence of domestic violence on pregnant women and maternal and neonatal outcomes in Bandar Abbas, Iran. Electron Physician. 2017;9(8):5166-5171doi: 10.19082/5166.
Nejatizade, A. A., Roozbeh, N., Yabandeh, A. P., Dabiri, F., Kamjoo, A., & Shahi, A. (2017). Prevalence of domestic violence on pregnant women and maternal and neonatal outcomes in Bandar Abbas, Iran. Electronic physician, 9(8), 5166-5171. https://doi.org/10.19082/5166
Nejatizade, Abdol Azim, et al. "Prevalence of domestic violence on pregnant women and maternal and neonatal outcomes in Bandar Abbas, Iran." Electronic physician vol. 9,8 (2017): 5166-5171. doi: https://doi.org/10.19082/5166
Nejatizade AA, Roozbeh N, Yabandeh AP, Dabiri F, Kamjoo A, Shahi A. Prevalence of domestic violence on pregnant women and maternal and neonatal outcomes in Bandar Abbas, Iran. Electron Physician. 2017 Aug 01;9(8):5166-5171. doi: 10.19082/5166. eCollection 2017 Aug. PMID: 28979757; PMCID: PMC5614307.
Copy Download .nbib Format: NLM
Effects of Intravenous Fluid Therapy on Clinical and Biochemical Parameters of Trauma Patients.

Emergency (Tehran, Iran)

Paydar S, Bazrafkan H, Golestani N, Roozbeh J, Akrami A, Moradi AM.
PMID: 26495354
Emerg (Tehran). 2014;2(2):90-5.

INTRODUCTION: The administration of crystalloid fluids is considered as the first line treatment in management of trauma patients. Infusion of intravenous fluids leads to various changes in hemodynamic, metabolic and coagulation profiles of these patients. The present study attempted...

Cite
Paydar S, Bazrafkan H, Golestani N, et al. Effects of Intravenous Fluid Therapy on Clinical and Biochemical Parameters of Trauma Patients. Emerg (Tehran). 2014;2(2):90-5
Paydar, S., Bazrafkan, H., Golestani, N., Roozbeh, J., Akrami, A., & Moradi, A. M. (2014). Effects of Intravenous Fluid Therapy on Clinical and Biochemical Parameters of Trauma Patients. Emergency (Tehran, Iran), 2(2), 90-5.
Paydar, Shahram, et al. "Effects of Intravenous Fluid Therapy on Clinical and Biochemical Parameters of Trauma Patients." Emergency (Tehran, Iran) vol. 2,2 (2014): 90-5.
Paydar S, Bazrafkan H, Golestani N, Roozbeh J, Akrami A, Moradi AM. Effects of Intravenous Fluid Therapy on Clinical and Biochemical Parameters of Trauma Patients. Emerg (Tehran). 2014;2(2):90-5. PMID: 26495354; PMCID: PMC4614590.
Copy Download .nbib Format: NLM
Senior-Loken syndrome secondary to NPHP5/IQCB1 mutation in an Iranian family.

NDT plus

Haghighi A, Al-Hamed M, Al-Hissi S, Hynes AM, Sharifian M, Roozbeh J, Saleh-Gohari N, Sayer JA.
PMID: 25984213
NDT Plus. 2011 Dec;4(6):421-3. doi: 10.1093/ndtplus/sfr096. Epub 2011 Aug 18.

Senior-Loken syndrome (SLS) is a rare autosomal recessive disease characterized by nephronophthisis and early-onset retinal degeneration. We used a large Iranian family with SLS to establish a molecular genetic diagnosis. Following clinical evaluation, we undertook homozygosity mapping in two...

Cite
Haghighi A, Al-Hamed M, Al-Hissi S, et al. Senior-Loken syndrome secondary to NPHP5/IQCB1 mutation in an Iranian family. NDT Plus. 2011;4(6):421-3doi: 10.1093/ndtplus/sfr096.
Haghighi, A., Al-Hamed, M., Al-Hissi, S., Hynes, A. M., Sharifian, M., Roozbeh, J., Saleh-Gohari, N., & Sayer, J. A. (2011). Senior-Loken syndrome secondary to NPHP5/IQCB1 mutation in an Iranian family. NDT plus, 4(6), 421-3. https://doi.org/10.1093/ndtplus/sfr096
Haghighi, Alireza, et al. "Senior-Loken syndrome secondary to NPHP5/IQCB1 mutation in an Iranian family." NDT plus vol. 4,6 (2011): 421-3. doi: https://doi.org/10.1093/ndtplus/sfr096
Haghighi A, Al-Hamed M, Al-Hissi S, Hynes AM, Sharifian M, Roozbeh J, Saleh-Gohari N, Sayer JA. Senior-Loken syndrome secondary to NPHP5/IQCB1 mutation in an Iranian family. NDT Plus. 2011 Dec;4(6):421-3. doi: 10.1093/ndtplus/sfr096. Epub 2011 Aug 18. PMID: 25984213; PMCID: PMC4421651.
Copy Download .nbib Format: NLM
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?.

Neurology international

Almasi M, Razmeh S, Habibi AH, Rezaee AH.
PMID: 27441068
Neurol Int. 2016 Jun 29;8(2):6617. doi: 10.4081/ni.2016.6617. eCollection 2016 Jun 15.

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A...

Cite
Almasi M, Razmeh S, Habibi AH, et al. Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?. Neurol Int. 2016;8(2):6617doi: 10.4081/ni.2016.6617.
Almasi, M., Razmeh, S., Habibi, A. H., & Rezaee, A. H. (2016). Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?. Neurology international, 8(2), 6617. https://doi.org/10.4081/ni.2016.6617
Almasi, Mostafa, et al. "Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?." Neurology international vol. 8,2 (2016): 6617. doi: https://doi.org/10.4081/ni.2016.6617
Almasi M, Razmeh S, Habibi AH, Rezaee AH. Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?. Neurol Int. 2016 Jun 29;8(2):6617. doi: 10.4081/ni.2016.6617. eCollection 2016 Jun 15. PMID: 27441068; PMCID: PMC4935817.
Copy Download .nbib Format: NLM
Zinc level and prevalence of rejection in transplanted patients.

Iranian Red Crescent medical journal

Roozbeh J, Sharifian Dorche M, Afshariani R.
PMID: 22737533
Iran Red Crescent Med J. 2011 Aug;13(8):594. Epub 2011 Aug 01.

No abstract available.

Cite
Roozbeh J, Sharifian Dorche M, Afshariani R. Zinc level and prevalence of rejection in transplanted patients. Iran Red Crescent Med J. 2011;13(8):594
Roozbeh, J., Sharifian Dorche, M., & Afshariani, R. (2011). Zinc level and prevalence of rejection in transplanted patients. Iranian Red Crescent medical journal, 13(8), 594.
Roozbeh, J, et al. "Zinc level and prevalence of rejection in transplanted patients." Iranian Red Crescent medical journal vol. 13,8 (2011): 594.
Roozbeh J, Sharifian Dorche M, Afshariani R. Zinc level and prevalence of rejection in transplanted patients. Iran Red Crescent Med J. 2011 Aug;13(8):594. Epub 2011 Aug 01. PMID: 22737533; PMCID: PMC3372002.
Copy Download .nbib Format: NLM
Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments.

Neurology international

Razmeh S, Habibi AH, Orooji M, Alizadeh E, Moradiankokhdan K, Razmeh B.
PMID: 29844889
Neurol Int. 2018 Apr 04;10(1):7516. doi: 10.4081/ni.2018.7516. eCollection 2018 Mar 30.

Pantothenate Kinase-Associated Neurodegeneration (PKAN) is an autosomal recessive disorder characterized by a mutation in the

Cite
Razmeh S, Habibi AH, Orooji M, et al. Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments. Neurol Int. 2018;10(1):7516doi: 10.4081/ni.2018.7516.
Razmeh, S., Habibi, A. H., Orooji, M., Alizadeh, E., Moradiankokhdan, K., & Razmeh, B. (2018). Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments. Neurology international, 10(1), 7516. https://doi.org/10.4081/ni.2018.7516
Razmeh, Saeed, et al. "Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments." Neurology international vol. 10,1 (2018): 7516. doi: https://doi.org/10.4081/ni.2018.7516
Razmeh S, Habibi AH, Orooji M, Alizadeh E, Moradiankokhdan K, Razmeh B. Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments. Neurol Int. 2018 Apr 04;10(1):7516. doi: 10.4081/ni.2018.7516. eCollection 2018 Mar 30. PMID: 29844889; PMCID: PMC5937219.
Copy Download .nbib Format: NLM
Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease.

Kidney research and clinical practice

Ezzatzadegan Jahromi S, Haghighi G, Roozbeh J, Ebrahimi V.
PMID: 30970391
Kidney Res Clin Pract. 2019 Jun 30;38(2):212-219. doi: 10.23876/j.krcp.18.0109.

BACKGROUND: Automated office blood pressure (AOBP) machines measure blood pressure (BP) multiple times over a brief period. We aimed to compare the results of manual office blood pressure (MOBP) and AOBP methods with ambulatory BP monitoring (ABPM) in patients...

Cite
Ezzatzadegan Jahromi S, Haghighi G, Roozbeh J, et al. Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease. Kidney Res Clin Pract. 2019;38(2):212-219doi: 10.23876/j.krcp.18.0109.
Ezzatzadegan Jahromi, S., Haghighi, G., Roozbeh, J., & Ebrahimi, V. (2019). Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease. Kidney research and clinical practice, 38(2), 212-219. https://doi.org/10.23876/j.krcp.18.0109
Ezzatzadegan Jahromi, Shahrokh, et al. "Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease." Kidney research and clinical practice vol. 38,2 (2019): 212-219. doi: https://doi.org/10.23876/j.krcp.18.0109
Ezzatzadegan Jahromi S, Haghighi G, Roozbeh J, Ebrahimi V. Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease. Kidney Res Clin Pract. 2019 Jun 30;38(2):212-219. doi: 10.23876/j.krcp.18.0109. PMID: 30970391; PMCID: PMC6577220.
Copy Download .nbib Format: NLM
Kidney Transplant and Autosomal Recessive Polycystic Disease: A Case Report and Literature Review of 2 Brothers.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation

Roozbeh J, Dehghani A, Haghpanah A, Doostkam A, Malekmakan L.
PMID: 33736581
Exp Clin Transplant. 2021 Apr;19(4):378-381. doi: 10.6002/ect.2020.0375. Epub 2021 Mar 16.

Autosomal recessive polycystic disease is a rare hepatorenal disorder. End-stage renal disease and liver fibrosis are serious presentations of this disease. Here, we report 2 brothers with autosomal recessive polycystic disease who presented with abnormal abdominal protrusion and hepatosplenomegaly...

Cite
Roozbeh J, Dehghani A, Haghpanah A, et al. Kidney Transplant and Autosomal Recessive Polycystic Disease: A Case Report and Literature Review of 2 Brothers. Exp Clin Transplant. 2021;19(4):378-381doi: 10.6002/ect.2020.0375.
Roozbeh, J., Dehghani, A., Haghpanah, A., Doostkam, A., & Malekmakan, L. (2021). Kidney Transplant and Autosomal Recessive Polycystic Disease: A Case Report and Literature Review of 2 Brothers. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 19(4), 378-381. https://doi.org/10.6002/ect.2020.0375
Roozbeh, Jamshid, et al. "Kidney Transplant and Autosomal Recessive Polycystic Disease: A Case Report and Literature Review of 2 Brothers." Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation vol. 19,4 (2021): 378-381. doi: https://doi.org/10.6002/ect.2020.0375
Roozbeh J, Dehghani A, Haghpanah A, Doostkam A, Malekmakan L. Kidney Transplant and Autosomal Recessive Polycystic Disease: A Case Report and Literature Review of 2 Brothers. Exp Clin Transplant. 2021 Apr;19(4):378-381. doi: 10.6002/ect.2020.0375. Epub 2021 Mar 16. PMID: 33736581.
Copy Download .nbib Format: NLM
Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.

Prostate cancer and prostatic diseases

Haghpanah A, Masjedi F, Salehipour M, Hosseinpour A, Roozbeh J, Dehghani A.
PMID: 34007019
Prostate Cancer Prostatic Dis. 2021 May 18; doi: 10.1038/s41391-021-00388-3. Epub 2021 May 18.

BACKGROUND: To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater risks of BPH complications such as acute urinary retention.METHODS: A categorized and comprehensive search in...

Cite
Haghpanah A, Masjedi F, Salehipour M, et al. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate Cancer Prostatic Dis. 2021;doi: 10.1038/s41391-021-00388-3.
Haghpanah, A., Masjedi, F., Salehipour, M., Hosseinpour, A., Roozbeh, J., & Dehghani, A. (2021). Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate cancer and prostatic diseases, . https://doi.org/10.1038/s41391-021-00388-3
Haghpanah, Abdolreza, et al. "Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review." Prostate cancer and prostatic diseases vol. (2021). doi: https://doi.org/10.1038/s41391-021-00388-3
Haghpanah A, Masjedi F, Salehipour M, Hosseinpour A, Roozbeh J, Dehghani A. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate Cancer Prostatic Dis. 2021 May 18; doi: 10.1038/s41391-021-00388-3. Epub 2021 May 18. PMID: 34007019; PMCID: PMC8129694.
Copy Download .nbib Format: NLM
The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire.

Iranian journal of allergy, asthma, and immunology

Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J.
PMID: 34920655
Iran J Allergy Asthma Immunol. 2021 Dec 08;20(6):721-733. doi: 10.18502/ijaai.v20i6.8023.

Natural killer (NK) cells are essential for controlling certain viral infections, including cytomegalovirus (CMV). In particular, the importance of NK cells in the context of CMV infection is underscored by the adaptive capabilities of these cells. Evidence suggests that...

Cite
Soleimanian S, Yaghobi R, Karimi MH, et al. The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire. Iran J Allergy Asthma Immunol. 2021;20(6):721-733doi: 10.18502/ijaai.v20i6.8023.
Soleimanian, S., Yaghobi, R., Karimi, M. H., Geramizadeh, B., & Roozbeh, J. (2021). The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire. Iranian journal of allergy, asthma, and immunology, 20(6), 721-733. https://doi.org/10.18502/ijaai.v20i6.8023
Soleimanian, Saeede, et al. "The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire." Iranian journal of allergy, asthma, and immunology vol. 20,6 (2021): 721-733. doi: https://doi.org/10.18502/ijaai.v20i6.8023
Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J. The Direct Influence of Cytomegalovirus Lysate on the Natural Killer Cell Receptor Repertoire. Iran J Allergy Asthma Immunol. 2021 Dec 08;20(6):721-733. doi: 10.18502/ijaai.v20i6.8023. PMID: 34920655.
Copy Download .nbib Format: NLM
The Impact of Coronavirus Disease 2019 on Sexual Health.

Galen medical journal

Banaei M, Ghasemi V, Dordeh M, Roozbeh N.
PMID: 34466615
Galen Med J. 2020 Dec 26;9:e1928. doi: 10.31661/gmj.v9i0.1928. eCollection 2020.

No abstract available.

Cite
Banaei M, Ghasemi V, Dordeh M, et al. The Impact of Coronavirus Disease 2019 on Sexual Health. Galen Med J. 2020;9:e1928doi: 10.31661/gmj.v9i0.1928.
Banaei, M., Ghasemi, V., Dordeh, M., & Roozbeh, N. (2020). The Impact of Coronavirus Disease 2019 on Sexual Health. Galen medical journal, 9e1928. https://doi.org/10.31661/gmj.v9i0.1928
Banaei, Mojdeh, et al. "The Impact of Coronavirus Disease 2019 on Sexual Health." Galen medical journal vol. 9 (2020): e1928. doi: https://doi.org/10.31661/gmj.v9i0.1928
Banaei M, Ghasemi V, Dordeh M, Roozbeh N. The Impact of Coronavirus Disease 2019 on Sexual Health. Galen Med J. 2020 Dec 26;9:e1928. doi: 10.31661/gmj.v9i0.1928. eCollection 2020. PMID: 34466615; PMCID: PMC8343610.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 96 entries